Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shalini Dogra

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Molecular Biology of the Cell|February 24, 2017
Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activationPunita Kumari, Ashish Srivastava, Eshan Ghosh, et al.
ACS Chemical Neuroscience|August 27, 2024
Kappa Opioid Receptor Activation Induces Epigenetic Silencing of Brain-Derived Neurotropic Factor <i>via</i> HDAC5 in DepressionAnubhav Yadav, Shalini Dogra, Arun Kumar Boda, et al.
Psychoneuroendocrinology|November 21, 2018
Chronic histamine 3 receptor antagonism alleviates depression like conditions in mice via modulation of brain-derived neurotrophic factor and hypothalamus-pituitary adrenal axisAjeet Kumar, Shalini Dogra, Chandan Sona, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Reciprocal regulation of the H<sub>3</sub> histamine receptor in Rett syndrome and <i>MECP2</i> Duplication syndrome: implications for therapeutic developmentKelly Weiss, Sheryl A D Vermudez, Geanne Freitas, et al.
Neuropharmacology|May 4, 2023
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disordersFerdinando Nicoletti, Luisa Di Menna, Luisa Iacovelli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2021
Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu<sub>3</sub>) impairs postsynaptic plasticity and modulates affective behaviorsMax E Joffe, Chiaki I Santiago, Sheryl Anne D Vermudez, et al.
Journal of Medicinal Chemistry|July 21, 2017
Opioid Receptor Modulators with a Cinnamyl GroupLokesh Ravilla, N Venkata Subba Naidu, Shalini Dogra, et al.
Pediatric Research|November 1, 2002
Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescentsAneeta Patel, Sissy Jhiang, Shalini Dogra, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescentsRima Shah, Kevin Banks, Aneeta Patel, et al.
Biological Psychiatry|December 7, 2023
Activation of Metabotropic Glutamate Receptor 3 Modulates Thalamo-accumbal Transmission and Rescues Schizophrenia-Like Physiological and Behavioral DeficitsShalini Dogra, Caleb Aguayo, Zixiu Xiang, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Molecular Biology of the Cell|February 24, 2017
Core engagement with β-arrestin is dispensable for agonist-induced vasopressin receptor endocytosis and ERK activationPunita Kumari, Ashish Srivastava, Eshan Ghosh, et al.
ACS Chemical Neuroscience|August 27, 2024
Kappa Opioid Receptor Activation Induces Epigenetic Silencing of Brain-Derived Neurotropic Factor <i>via</i> HDAC5 in DepressionAnubhav Yadav, Shalini Dogra, Arun Kumar Boda, et al.
Psychoneuroendocrinology|November 21, 2018
Chronic histamine 3 receptor antagonism alleviates depression like conditions in mice via modulation of brain-derived neurotrophic factor and hypothalamus-pituitary adrenal axisAjeet Kumar, Shalini Dogra, Chandan Sona, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Reciprocal regulation of the H<sub>3</sub> histamine receptor in Rett syndrome and <i>MECP2</i> Duplication syndrome: implications for therapeutic developmentKelly Weiss, Sheryl A D Vermudez, Geanne Freitas, et al.
Neuropharmacology|May 4, 2023
GPCR interactions involving metabotropic glutamate receptors and their relevance to the pathophysiology and treatment of CNS disordersFerdinando Nicoletti, Luisa Di Menna, Luisa Iacovelli, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 26, 2021
Frontal cortex genetic ablation of metabotropic glutamate receptor subtype 3 (mGlu<sub>3</sub>) impairs postsynaptic plasticity and modulates affective behaviorsMax E Joffe, Chiaki I Santiago, Sheryl Anne D Vermudez, et al.
Journal of Medicinal Chemistry|July 21, 2017
Opioid Receptor Modulators with a Cinnamyl GroupLokesh Ravilla, N Venkata Subba Naidu, Shalini Dogra, et al.
Pediatric Research|November 1, 2002
Differentiated thyroid carcinoma that express sodium-iodide symporter have a lower risk of recurrence for children and adolescentsAneeta Patel, Sissy Jhiang, Shalini Dogra, et al.
The Journal of Clinical Endocrinology and Metabolism|September 6, 2002
Intense expression of the b7-2 antigen presentation coactivator is an unfavorable prognostic indicator for differentiated thyroid carcinoma of children and adolescentsRima Shah, Kevin Banks, Aneeta Patel, et al.
Biological Psychiatry|December 7, 2023
Activation of Metabotropic Glutamate Receptor 3 Modulates Thalamo-accumbal Transmission and Rescues Schizophrenia-Like Physiological and Behavioral DeficitsShalini Dogra, Caleb Aguayo, Zixiu Xiang, et al.
Pageof 3